Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+5.45% | 72.01B | |
+30.80% | 10.39B | |
+41.28% | 5.26B | |
-18.53% | 4.64B | |
+18.24% | 3.7B | |
+26.86% | 2.3B | |
-39.52% | 1.8B | |
-45.54% | 1.7B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Stallergenes Greer plc Announces Resignation of Peter Bühler as Chief Financial Officer Effective April 28, 2017